Manchester Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-136
Closed -$1K 567
2019
Q1
$1K Buy
+136
New +$1K ﹤0.01% 635